Luma Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Luma Therapeutics General Information

Description

Developer of a medical device designed to treat inflammatory skin disorders. The company's device is a medical margin disposable patch for rapid and affordable treatment of skin disorders at home, enabling patients to treat and cure skin disorders like psoriasis at low cost.

Contact Information

Formerly Known As
Illumicure
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 10 Rollins Road
  • Suite 120
  • Millbrae, CA 94030
  • United States
+1 (415)
Primary Industry
Therapeutic Devices
Corporate Office
  • 10 Rollins Road
  • Suite 120
  • Millbrae, CA 94030
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Luma Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Mar-2021 Completed Out of Business
6. Later Stage VC (Series A1) 19-Dec-2019 Cancelled Generating Revenue
5. Accelerator/Incubator 09-May-2018 Completed Generating Revenue
4. Early Stage VC (Series A) 15-Feb-2017 Completed Generating Revenue
3. Seed Round 22-Apr-2016 Completed Generating Revenue
2. Grant 16-Apr-2016 $15K $550K Completed Generating Revenue
1. Seed Round 01-Nov-2014 $550K $550K Completed Startup
To view Luma Therapeutics’s complete valuation and funding history, request access »

Luma Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
Seed 7,000,000 $0.000100 $0.02 $0.24 $0.24 1x $0.24 15.92%
To view Luma Therapeutics’s complete cap table history, request access »

Luma Therapeutics Patents

Luma Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3568194-A2 Uvb light therapy for immune disorders Inactive 13-Jan-2017
US-20200121943-A1 Uvb light therapy for immune disorders Inactive 13-Jan-2017
AU-2017217839-A1 Methods, compositions and apparatuses for treating psoriasis by phototherapy Inactive 09-Feb-2016
EP-3413852-A1 Methods, compositions and apparatuses for treating psoriasis by phototherapy Inactive 09-Feb-2016
EP-3413852-A4 Methods, compositions and apparatuses for treating psoriasis by phototherapy Inactive 09-Feb-2016 A61N5/0616
To view Luma Therapeutics’s complete patent history, request access »

Luma Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Luma Therapeutics FAQs

  • When was Luma Therapeutics founded?

    Luma Therapeutics was founded in 2013.

  • Where is Luma Therapeutics headquartered?

    Luma Therapeutics is headquartered in Millbrae, CA.

  • What is the size of Luma Therapeutics?

    Luma Therapeutics has 6 total employees.

  • What industry is Luma Therapeutics in?

    Luma Therapeutics’s primary industry is Therapeutic Devices.

  • Is Luma Therapeutics a private or public company?

    Luma Therapeutics is a Private company.

  • What is Luma Therapeutics’s current revenue?

    The current revenue for Luma Therapeutics is .

  • How much funding has Luma Therapeutics raised over time?

    Luma Therapeutics has raised $3.35M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »